DE59404726D1 - Angiogenin und/oder alpha1-microglobulin und/oder komplementfaktor d zur begrenzung der sekretion von proteinen - Google Patents

Angiogenin und/oder alpha1-microglobulin und/oder komplementfaktor d zur begrenzung der sekretion von proteinen

Info

Publication number
DE59404726D1
DE59404726D1 DE59404726T DE59404726T DE59404726D1 DE 59404726 D1 DE59404726 D1 DE 59404726D1 DE 59404726 T DE59404726 T DE 59404726T DE 59404726 T DE59404726 T DE 59404726T DE 59404726 D1 DE59404726 D1 DE 59404726D1
Authority
DE
Germany
Prior art keywords
secretion
alpha1
angiogenin
microglobulin
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE59404726T
Other languages
English (en)
Inventor
Harald Tschesche
Ute Hempelmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE59404726D1 publication Critical patent/DE59404726D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE59404726T 1993-03-23 1994-03-23 Angiogenin und/oder alpha1-microglobulin und/oder komplementfaktor d zur begrenzung der sekretion von proteinen Expired - Fee Related DE59404726D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4309391A DE4309391C2 (de) 1993-03-23 1993-03-23 Verwendung von Angiogenin und/oder dessen Fragmenten als Wirkstoff zur Verhinderung oder Begrenzung der Sekretion von Proteinen aus Leukozyten
PCT/DE1994/000333 WO1994021273A2 (de) 1993-03-23 1994-03-23 VERWENDUNG VON ANGIOGENIN UND/ODER α1-MICROGLOBULIN UND/ODER KOMPLEMENTFAKTOR D ZUR BEGRENZUNG DER SEKRETION VON PROTEINEN

Publications (1)

Publication Number Publication Date
DE59404726D1 true DE59404726D1 (de) 1998-01-15

Family

ID=6483611

Family Applications (2)

Application Number Title Priority Date Filing Date
DE4309391A Expired - Fee Related DE4309391C2 (de) 1993-03-23 1993-03-23 Verwendung von Angiogenin und/oder dessen Fragmenten als Wirkstoff zur Verhinderung oder Begrenzung der Sekretion von Proteinen aus Leukozyten
DE59404726T Expired - Fee Related DE59404726D1 (de) 1993-03-23 1994-03-23 Angiogenin und/oder alpha1-microglobulin und/oder komplementfaktor d zur begrenzung der sekretion von proteinen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE4309391A Expired - Fee Related DE4309391C2 (de) 1993-03-23 1993-03-23 Verwendung von Angiogenin und/oder dessen Fragmenten als Wirkstoff zur Verhinderung oder Begrenzung der Sekretion von Proteinen aus Leukozyten

Country Status (4)

Country Link
EP (1) EP0689448B1 (de)
AT (1) ATE160698T1 (de)
DE (2) DE4309391C2 (de)
WO (1) WO1994021273A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9603465D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727137A (en) * 1985-04-17 1988-02-23 President And Fellows Of Harvard College Purified protein having angiogenic activity and methods of preparation
EP0255011A3 (de) * 1986-07-29 1988-11-23 Miles Inc. Menschliches Inter-alpha-trypsin-Inhibitorgen
US4900673A (en) * 1988-03-28 1990-02-13 President And Fellows Of Harvard College Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression

Also Published As

Publication number Publication date
WO1994021273A3 (de) 1994-12-08
EP0689448A1 (de) 1996-01-03
ATE160698T1 (de) 1997-12-15
EP0689448B1 (de) 1997-12-03
DE4309391C2 (de) 1996-10-24
DE4309391A1 (de) 1994-09-29
WO1994021273A2 (de) 1994-09-29

Similar Documents

Publication Publication Date Title
DE3789371D1 (de) Aryloxy- und Arylacyloxymethyl-Ketone als Thiolprotease-Hemmungsstoffe.
DE3852909T2 (de) Lineare Kette von Parallelprozessoren und Benutzungsverfahren davon.
DE3581881D1 (de) Modifizierter membranunterdruecker und anwendungsverfahren.
ES8602768A1 (es) Un procedimiento para la preparacion de nuevas n-(heterociclil biciclo)-4-piperidinaminas.
DE69411692D1 (de) Mittel zur Förderung der Proliferationen von Bifidobacterium
DE3674642D1 (de) Zur modifizierung von bitumen verwendbare polymerzusammensetzungen und so modifizierte bitumenmassen.
DE3483069D1 (de) Ko-raffination von aramidfibrillen und flocken.
ATE120206T1 (de) Peptide, die die bindung des von-willebrand- faktors inhibieren.
DE69032207D1 (de) Einführung von bakterien in ovo
DE3574634D1 (de) Aufbereitung und ueberpruefung von farbanzeigeeigenschaften von nichtaktiven profilen.
DE3481307D1 (de) Aglykone und pseudo-aglykone von aad-216-antibiotika.
DE3789530D1 (de) Klonierung und Expression des sauren Fibroblastenwachstumsfaktors.
DE3850433D1 (de) Allergiebehandlung und Zusammensetzung dafür.
DE3673217D1 (de) Phenylalkyl-2,3-dihydrobenzofurane und analoga zur verwendung als antientzuendungsmittel.
DE3885913D1 (de) Aufbereitung von Alkoxysilanen.
DE3852625T2 (de) Vektoren und Verbindungen zur Expression von Zymogen-Formen von menschlichem Protein C.
DE59404726D1 (de) Angiogenin und/oder alpha1-microglobulin und/oder komplementfaktor d zur begrenzung der sekretion von proteinen
DE69002558T2 (de) Zusammensetzungen und Methoden zur Verhinderung von Inkrustierungen.
DE3881123T2 (de) Klonieren von für einen antibakteriellen Polypeptidvorläufer kodierender DNA und Expression des Vorläufers.
NO881502D0 (no) Rekombinante htlv-111 proteiner og anvendelse av disse.
DE68913779T2 (de) D-Amidase und Verfahren zur Herstellung von D-alpha-Alanin und/oder L-alpha-Alaninamid.
DE3769497D1 (de) Mittel zur bekaempfung von phytopathogenen mikroben.
DE3881991T2 (de) Zusammensetzung von Gleitgliedern.
DE59003265D1 (de) Verwendung von nor-verapamil und nor-gallopamil als antiarteriosklerotica.
ATA277176A (de) Einrichtung zur biologischen aufbereitung von mull oder von mull-klarschlamm-gemischen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee